Akihiko Nishikimi

Dr. Akihiko Nishikimi

Biosafety Division, Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi 474-8511, Japan

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2009 in Science
Verified
Journal Article
Closed access
PDF file
ANAkihiko Nishikimi
Akihiko Nishikimi
HFHideo Fukuhara
Hideo Fukuhara
WSWenjuan Su
Wenjuan Su
THTsunaki Hongu
Tsunaki Hongu
STShunsuke Takasuga
Shunsuke Takasuga
YFYoshinori Fukui
Yoshinori Fukui
During chemotaxis, activation of the small guanosine triphosphatase Rac is spatially regulated to organize the extension of membrane protrusions in the direction of migration. In neutrophils, Rac activation is primarily mediated by DOCK2, an atypical guanine nucleotide exchange factor. Upon stimulation, we found that DOCK2 rapidly translocated to the plasma membrane in a phosphatidylinositol 3,4,5-trisphosphate–dependent manner. However, subsequent accumulation of DOCK2 at the leading edge required phospholipase D–mediated synthesis of phosphatidic acid, which stabilized DOCK2 there by means of interaction with a polybasic amino acid cluster, resulting in increased local actin polymerization. When this interaction was blocked, neutrophils failed to form leading edges properly and exhibited defects in chemotaxis. Thus, intracellular DOCK2 dynamics are sequentially regulated by distinct phospholipids to localize Rac activation during neutrophil chemotaxis.

10 May 2012 in Blood
Verified
Journal Article
Open access
PDF file
YHYosuke Harada
Yosuke Harada
YTYoshihiko Tanaka
Yoshihiko Tanaka
MTMasao Terasawa
Masao Terasawa
MPMarkus Pieczyk
Markus Pieczyk
KHKatsuyoshi Habiro
Katsuyoshi Habiro
YFYoshinori Fukui
Yoshinori Fukui
To migrate efficiently through the interstitium, dendritic cells (DCs) constantly adapt their shape to the given structure of the extracellular matrix and follow the path of least resistance. It is known that this amoeboid migration of DCs requires Cdc42, yet the upstream regulators critical for localization and activation of Cdc42 remain to be determined. Mutations of DOCK8, a member of the atypical guanine nucleotide exchange factor family, causes combined immunodeficiency in humans. In the present study, we show that DOCK8 is a Cdc42-specific guanine nucleotide exchange factor that is critical for interstitial DC migration. By generating the knockout mice, we found that in the absence of DOCK8, DCs failed to accumulate in the lymph node parenchyma for T-cell priming. Although DOCK8-deficient DCs migrated normally on 2-dimensional surfaces, DOCK8 was required for DCs to crawl within 3-dimensional fibrillar networks and to transmigrate through the subcapsular sinus floor. This function of DOCK8 depended on the DHR-2 domain mediating Cdc42 activation. DOCK8 deficiency did not affect global Cdc42 activity. However, Cdc42 activation at the leading edge membrane was impaired in DOCK8-deficient DCs, resulting in a severe defect in amoeboid polarization and migration. Therefore, DOCK8 regulates interstitial DC migration by controlling Cdc42 activity spatially.

28 August 2006 in Journal of Cell Biology
Verified
Journal Article
Open access
YKYuya Kunisaki
Yuya Kunisaki
ANAkihiko Nishikimi
Akihiko Nishikimi
YTYoshihiko Tanaka
Yoshihiko Tanaka
RTRyosuke Takii
Ryosuke Takii
MNMayuko Noda
Mayuko Noda
YFYoshinori Fukui
Yoshinori Fukui
Neutrophils are highly motile leukocytes, and they play important roles in the innate immune response to invading pathogens. Neutrophil chemotaxis requires Rac activation, yet the Rac activators functioning downstream of chemoattractant receptors remain to be determined. We show that DOCK2, which is a mammalian homologue of Caenorhabditis elegans CED-5 and Drosophila melanogaster Myoblast City, regulates motility and polarity during neutrophil chemotaxis. Although DOCK2-deficient neutrophils moved toward the chemoattractant source, they exhibited abnormal migratory behavior with a marked reduction in translocation speed. In DOCK2-deficient neutrophils, chemoattractant-induced activation of both Rac1 and Rac2 were severely impaired, resulting in the loss of polarized accumulation of F-actin and phosphatidylinositol 3,4,5-triphosphate (PIP3) at the leading edge. On the other hand, we found that DOCK2 associates with PIP3 and translocates to the leading edge of chemotaxing neutrophils in a phosphatidylinositol 3-kinase (PI3K)–dependent manner. These results indicate that during neutrophil chemotaxis DOCK2 regulates leading edge formation through PIP3-dependent membrane translocation and Rac activation.

15 March 2010 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
KGKazuhito Gotoh
Kazuhito Gotoh
YTYoshihiko Tanaka
Yoshihiko Tanaka
ANAkihiko Nishikimi
Akihiko Nishikimi
RNRisa Nakamura
Risa Nakamura
HYHisakata Yamada
Hisakata Yamada
YFYoshinori Fukui
Yoshinori Fukui
Plasmacytoid dendritic cells (pDCs) play a key role in antiviral immunity, but also contribute to the pathogenesis of certain autoimmune diseases, by producing large amounts of type I IFNs. Although activation of pDCs is triggered by engagement of nucleotide-sensing toll-like receptors (TLR) 7 and 9, type I IFN induction additionally requires IκB kinase (IKK) α–dependent activation of IFN regulatory factor (IRF) 7. However, the signaling pathway mediating IKK-α activation is poorly defined. We show that DOCK2, an atypical Rac activator, is essential for TLR7- and TLR9-mediated IFN-α induction in pDCs. We found that the exposure of pDCs to nucleic acid ligands induces Rac activation through a TLR-independent and DOCK2-dependent mechanism. Although this Rac activation was dispensable for induction of inflammatory cytokines, phosphorylation of IKK-α and nuclear translocation of IRF-7 were impaired in Dock2-deficient pDCs, resulting in selective loss of IFN-α induction. Similar results were obtained when a dominant-negative Rac mutant was expressed in wild-type pDCs. Thus, the DOCK2–Rac signaling pathway acts in parallel with TLR engagement to control IKK-α activation for type I IFN induction. Owing to its hematopoietic cell-specific expression, DOCK2 may serve as a therapeutic target for type I IFN–related autoimmune diseases.

1 September 2013 in Experimental Cell Research
Verified
Journal Article
Closed access
ANAkihiko Nishikimi
Akihiko Nishikimi
MKMutsuko Kukimoto-Niino
Mutsuko Kukimoto-Niino
SYShigeyuki Yokoyama
Shigeyuki Yokoyama
YFYoshinori Fukui
Yoshinori Fukui

1 August 2013 in Developmental Cell
Verified
Journal Article
Closed access
SKSachiko Kamakura
Sachiko Kamakura
MNMasatoshi Nomura
Masatoshi Nomura
JHJunya Hayase
Junya Hayase
YIYuko Iwakiri
Yuko Iwakiri
ANAkihiko Nishikimi
Akihiko Nishikimi
HSHideki Sumimoto
Hideki Sumimoto